Some reports correlate the administration of all forms of interferon with the development or exacerbation of autoimmune phenomena and diseases, including sarcoidosis, because of the strong and complex immune action of interferons. We report on a case of sarcoidosis following beta-interferon treatment for multiple myeloma. Differently from what had been observed in all the 8 previously reported cases of associated multiple myeloma and sarcoidosis, where the plasmacellular malignancy followed the onset of the respiratory disease, in the case of our patient, sarcoidosis arose after multiple myeloma was first diagnosed
An unusual case of multiple myeloma with extramedullary dissemination and co-existing systemic non-n...
SummaryRecombinant interferon-α (rINF-α) is an immunomodulator used in the treatment of various cond...
Introduction There is a reported association between sarcoidosis and malignancy. This is particularl...
Some reports correlate the administration of all forms of interferon with the development or exacerb...
Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence...
International audienceInterferon alfa is widely used as adjuvant therapy for melanoma. Numerous side...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interfe...
The existence of a sarcoidosis-lymphoma syndrome has been previously proposed since the relation bet...
Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well know...
The association of sarcoidosis with multiple myeloma is not well known. Including this case report, ...
Hepatitis C virus (HCV) infection is a very common chronic infectious disease. Combined antiviral th...
Interferon (IFN)-alpha with or without ribavirin is the treatment of choice for patients with chroni...
Sarcoidosis is a systemic granulomatous disorder of unknown origin commonly affecting the lung, the ...
Despite proven efficacy of alemtuzumab in multiple sclerosis (MS), approximately 50% of individuals ...
An unusual case of multiple myeloma with extramedullary dissemination and co-existing systemic non-n...
SummaryRecombinant interferon-α (rINF-α) is an immunomodulator used in the treatment of various cond...
Introduction There is a reported association between sarcoidosis and malignancy. This is particularl...
Some reports correlate the administration of all forms of interferon with the development or exacerb...
Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence...
International audienceInterferon alfa is widely used as adjuvant therapy for melanoma. Numerous side...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interfe...
The existence of a sarcoidosis-lymphoma syndrome has been previously proposed since the relation bet...
Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well know...
The association of sarcoidosis with multiple myeloma is not well known. Including this case report, ...
Hepatitis C virus (HCV) infection is a very common chronic infectious disease. Combined antiviral th...
Interferon (IFN)-alpha with or without ribavirin is the treatment of choice for patients with chroni...
Sarcoidosis is a systemic granulomatous disorder of unknown origin commonly affecting the lung, the ...
Despite proven efficacy of alemtuzumab in multiple sclerosis (MS), approximately 50% of individuals ...
An unusual case of multiple myeloma with extramedullary dissemination and co-existing systemic non-n...
SummaryRecombinant interferon-α (rINF-α) is an immunomodulator used in the treatment of various cond...
Introduction There is a reported association between sarcoidosis and malignancy. This is particularl...